Get to know us
EPTRI is a Research Infrastructure aiming to promote paediatric research and provide optimal support to facilitate the accruing of knowledge in the many research fields necessary to guarantee the access to high quality and safe paediatric medicine
![002-witness](https://eptri.eu/wp-content/uploads/2021/04/002-witness.png)
VISION
To increase knowledge on children growth and ontogeny characteristics relevant for the identification of novel therapies dedicated to children and to provide services for their development
![001-startup](https://eptri.eu/wp-content/uploads/2021/04/001-startup.png)
MISSION
To implement competences, research strategies, access to key technologies, standardised models, and analytical tools and to offer to public and private stakeholders qualified basic, preclinical and translational research services covering paediatric medicines discovery and development
Latest News
Bluebird Bio’s Gene Therapy for Βeta-Thalassaemia granted FDA approval
The US Food and Drug Administration (FDA) has approved Bluebird Bio’s one-time beta-thalassaemia treatment Zynteglo, also known as betibeglogene...
HMA – EMA 3rd EU Big Data Stakeholder Forum
The Heads of Medicines Agencies - European Medicines Agency (HMA - EMA) Big Data Steering Group is organizing the 3rd EU Big Data Stakeholders Forum...
EMA’s Draft ICH Guideline M12 on drug interaction studies is open for public consultation
In clinical practice, patients are often prescribed more than one drug which can result in a drug-drug interaction (DDI). The European Medicines...